Bijal Shah
@bijlshah.bsky.social
Reposted by Bijal Shah
"Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant."
grants.nih.gov/grants/guide...
grants.nih.gov/grants/guide...
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
grants.nih.gov
February 7, 2025 at 11:37 PM
"Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant."
grants.nih.gov/grants/guide...
grants.nih.gov/grants/guide...
Reposted by Bijal Shah
(1/3) #ScienceSaturday
➡️ How does the history of T cells impact their ability to fight #cancer when engineered with chimeric antigen receptors?
➡️ How does the history of T cells impact their ability to fight #cancer when engineered with chimeric antigen receptors?
January 11, 2025 at 4:21 PM
(1/3) #ScienceSaturday
➡️ How does the history of T cells impact their ability to fight #cancer when engineered with chimeric antigen receptors?
➡️ How does the history of T cells impact their ability to fight #cancer when engineered with chimeric antigen receptors?
Reposted by Bijal Shah
Now online in Cancer Discovery: Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-Cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL by Yi-Jiun Su, Matthew Frank, and colleagues doi.org/10.1158/2159... @stanfordmedicine.bsky.social
January 7, 2025 at 8:06 PM
Now online in Cancer Discovery: Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-Cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL by Yi-Jiun Su, Matthew Frank, and colleagues doi.org/10.1158/2159... @stanfordmedicine.bsky.social
December 4, 2024 at 12:24 AM